Literature DB >> 3154641

Hemodynamic effects of nifedipine and oxygen in children with pulmonary hypertension.

M Wimmer1, M Schlemmer, F Ebner.   

Abstract

Fourteen patients, 2 to 20 years old were investigated. Two had primary pulmonary hypertension, 11 had congenital heart disease and post-tricuspid shunts, and 1, a 20-year-old patient, was investigated after he had undergone surgical correction of truncus arteriosus I. Pulmonary arterial pressure, pulmonary flow index, peripheral systolic blood pressure and heart rate were measured before, and several times after intrapulmonary injection into the pulmonary artery of 0.5 microgram nifedipine/kg. Six patients were given an additional dose of 1 microgram nifedipine per kilogram into the pulmonary artery and hemodynamic measurements were repeated. In eight children, receiving 100% oxygen via a breathing mask, nifedipine effects were compared with oxygen effects. After 10 minutes under oxygen, the same hemodynamics were determined as after nifedipine. In addition, in four of these children aortic pressure and arterial oxygen saturation were also measured. Maximal effects occurred within 4 minutes. 0.5 micrograms nifedipine per kilogram caused a slight reduction in mean pulmonary arterial pressure (p less than 0.05), as well as increase in pulmonary flow index (p less than 0.005). However, no significant change in heart rate or in systolic blood pressure was observed. 1 microgram nifedipine per kilogram IP had almost the same effects. No adverse side effects occurred, besides mild headaches in one child. A comparison of nifedipine injected into the pulmonary artery with oxygen breathing in congenital heart disease combined with pulmonary hypertension, is reported for the first time. Nifedipine had a more pronounced and beneficial effect with a selective action on the pulmonary vascular bed.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3154641     DOI: 10.1007/bf00054206

Source DB:  PubMed          Journal:  Cardiovasc Drugs Ther        ISSN: 0920-3206            Impact factor:   3.727


  28 in total

1.  The pathology of hypertensive pulmonary vascular disease; a description of six grades of structural changes in the pulmonary arteries with special reference to congenital cardiac septal defects.

Authors:  D HEATH; J E EDWARDS
Journal:  Circulation       Date:  1958-10       Impact factor: 29.690

Review 2.  Specific pharmacology of calcium in myocardium, cardiac pacemakers, and vascular smooth muscle.

Authors:  A Fleckenstein
Journal:  Annu Rev Pharmacol Toxicol       Date:  1977       Impact factor: 13.820

3.  Fate of the patient with the Eisenmenger syndrome.

Authors:  D Young; H Mark
Journal:  Am J Cardiol       Date:  1971-12       Impact factor: 2.778

4.  Natural history of ventricular septal defect.

Authors:  M Campbell
Journal:  Br Heart J       Date:  1971-03

5.  Pulmonary vascular resistance in children with congenital heart disease.

Authors:  N J Davies; E A Shinebourne; M J Scallan; T A Sopwith; D M Denison
Journal:  Thorax       Date:  1984-12       Impact factor: 9.139

6.  [Editorial: Indications for long-term-(home) O2-therapy (author's transl)].

Authors:  H Matthys
Journal:  Prax Klin Pneumol       Date:  1981-11

7.  Primary and secondary pulmonary hypertension in childhood: a clinicopathological reappraisal.

Authors:  S G Haworth
Journal:  Curr Top Pathol       Date:  1983

8.  [Hemodynamic studies of nifedipine (Adalat) in pulmonary hypertension in childhood].

Authors:  M Wimmer; M Schlemmer; F Ebner
Journal:  Wien Klin Wochenschr       Date:  1986-11-07       Impact factor: 1.704

9.  Vascular structure in lung tissue obtained at biopsy correlated with pulmonary hemodynamic findings after repair of congenital heart defects.

Authors:  M Rabinovitch; J F Keane; W I Norwood; A R Castaneda; L Reid
Journal:  Circulation       Date:  1984-04       Impact factor: 29.690

10.  High-dose calcium channel-blocking therapy for primary pulmonary hypertension: evidence for long-term reduction in pulmonary arterial pressure and regression of right ventricular hypertrophy.

Authors:  S Rich; B H Brundage
Journal:  Circulation       Date:  1987-07       Impact factor: 29.690

View more
  3 in total

1.  Long-term hemodynamic effects of nifedipine on congenital heart disease with Eisenmenger's mechanism in children.

Authors:  M Wimmer; M Schlemmer
Journal:  Cardiovasc Drugs Ther       Date:  1992-04       Impact factor: 3.727

Review 2.  Calcium channel blockers for pulmonary arterial hypertension.

Authors:  Zhiyu Fan; Yuanjing Chen; Hanmin Liu
Journal:  Cochrane Database Syst Rev       Date:  2015-09-25

3.  Inhaled nitric oxide applications in paediatric practice.

Authors:  A Bernasconi; M Beghetti
Journal:  Images Paediatr Cardiol       Date:  2002-01
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.